PDE5抑制恢复糖尿病中Tie2表达单核细胞与Ang1的血管生成稳态
本研究探讨2型糖尿病中Tie2表达单核细胞(TEMs)与血管生成素-1(Ang1)的关系及PDE5抑制剂西地那非的药理调节作用。采用随机双盲安慰剂对照设计,db/db小鼠接受8周西地那非或溶剂,糖尿病男性接受4周西地那非或安慰剂。结果显示糖尿病中TEMs和Ang1缺陷,西地那非治疗可使之正常化并恢复血清血管生成特性。
要点
- 糖尿病中TEMs和Ang1存在缺陷,西地那非治疗可使其正常化。
- 糖尿病血清血管生成特性受损,体内西地那非治疗可恢复。
- 西地那非通过恢复Tie2-Ang1轴促进血管生成稳态。
核心结论
- 西地那非通过恢复更生理性的Tie2-Ang1轴,重建糖尿病中的血清血管生成特性,促进血管生成稳态。
研究设计与样本
- 随机双盲安慰剂对照研究,db/db雄性小鼠随机接受8周西地那非或溶剂,糖尿病男性随机接受4周西地那非或安慰剂。
主要发现
- 在糖尿病小鼠和人类模型中TEMs和Ang1存在缺陷,PDE5抑制剂治疗可使之正常化。
- 糖尿病血清血管生成特性受损,不支持体外毛细管样结构形成,但体内PDE5抑制剂治疗可重建。
临床怎么用
- 西地那非可能通过恢复Tie2-Ang1轴改善糖尿病血管生成稳态,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Vascular dysfunction is a common feature in end-organ complications of type 2 diabetes mellitus (T2DM). The endothelium-specific receptor tyrosine kinase Tie2 and its ligand, angiopoietin-1 (Ang1), participate in the processes of vessel repair, renewal, and maturation. However, their dysregulation in T2DM has seldom been investigated. OBJECTIVES: To examine the relationship between angiogenic Tie2-expressing monocytes (TEMs) and Ang1, and their pharmacological modulation by the phosphodiesterase type 5 inhibitor (PDE5i) sildenafil, in T2DM and in db/db mouse model. DESIGN AND SETTING: Randomized, double-blind, placebo-controlled study. PATIENTS AND INTERVENTION: db/db male mice were randomly assigned to receive 8 weeks of sildenafil or vehicle. Diabetic men were randomly assigned to receive 4 weeks of sildenafil or placebo. MAIN OUTCOMES AND MEASURES: Peripheral blood cells were investigated by flow cytometry to quantify inflammatory myeloid CD11b+ Gr1+ cells and proangiogenic TEMs in mice and classical CD14++CD16neg monocytes and proangiogenic TEMs in humans at baseline and after treatment. In vitro human tube formation assay was used to test serum angiogenic potential. RESULTS: We show that TEMs and Ang1 are defective in mouse and human models of diabetes and are normalized by PDE5i treatment. Serum angiogenic properties are impaired in diabetes because they do not support the in vitro formation of capillary-like structures, but they are reestablished by in vivo PDE5i treatment. CONCLUSIONS: Restoring a more physiological Tie2-Ang1 axis with sildenafil reestablishes serum angiogenic properties in diabetes, promoting angiogenic homeostasis.
引用
- Venneri MA, Barbagallo F, Fiore D, et al. PDE5 Inhibition Stimulates Tie2-Expressing Monocytes and Angiopoietin-1 Restoring Angiogenic Homeostasis in Diabetes. J Clin Endocrinol Metab. 2019. PMID: 31102457. doi:10.1210/jc.2018-02525
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。